Gene · 2204
Papers1,603
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,603
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation. | Nat Commun | 2025 | 40301356 | PubTator, text mining | PubMed |
| Plasma Circulating Proteins and Intracranial Aneurysm Susceptibility: A Proteome-Wide Mendelian Randomization Analysis. | World Neurosurg | 2025 | 40294794 | PubTator, text mining | PubMed |
| Targeting ALPPL2 with a novel CD89 bispecific antibody reprograms macrophages to enhance anti-tumor immunity. | Biochem Biophys Res Commun | 2025 | 40209501 | PubTator, text mining | PubMed |
| IgA2 ACPA Drives a Hyper-Inflammatory Phenotype in Macrophages via ATP Synthase and COX2. | Eur J Immunol | 2025 | 40170376 | PubTator, text mining | PubMed |
| Enhancing activity of FcαRI-bispecific antibodies using glycoengineering. | J Immunol | 2025 | 40156381 | PubTator, text mining | PubMed |
| Engineering of anticancer human immunoglobulin A equipped with albumin for enhanced plasma half-life. | PNAS Nexus | 2025 | 40041621 | PubTator, text mining | PubMed |
| With great power, comes great responsibility: the importance of broadly measuring Fc-mediated effector function early in the antibody development process. | MAbs | 2025 | 39819511 | PubTator, text mining | PubMed |
| Interaction study of the effects of environmental exposure and gene polymorphisms of inflammatory and immune-active factors on chronic obstructive pulmonary disease. | Respir Res | 2025 | 39780163 | PubTator, text mining | PubMed |
| Underappreciated layers of antibody-mediated immune synapse architecture and dynamics. | mBio | 2025 | 39660921 | PubTator, text mining | PubMed |
| Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib. | Arthritis Rheumatol | 2025 | 39431356 | PubTator, text mining | PubMed |
| The pathogenesis of IgA nephropathy and implications for treatment. | Nat Rev Nephrol | 2025 | 39232245 | PubTator, text mining | PubMed |
| Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-inflammatory Pathways. | Curr Pharm Biotechnol | 2025 | 39129161 | PubTator, text mining | PubMed |
| Screening and Identification of Neutrophil Extracellular Trap-related Diagnostic Biomarkers for Pediatric Sepsis by Machine Learning. | Inflammation | 2025 | 38795170 | PubTator, text mining | PubMed |
| Dapsone Alters Phenotypical and Functional Properties of Human Neutrophils In Vitro. | Molecules | 2024 | 39795170 | PubTator, text mining | PubMed |
| Single-cell data revealed the function of natural killer cells and macrophage cells in chemotherapy tolerance in acute myeloid leukemia. | PeerJ | 2024 | 39583114 | PubTator, text mining | PubMed |
| Circulating mucosal-like IgA responses increase with severity of Puumala orthohantavirus-caused hemorrhagic fever with renal syndrome. | Front Immunol | 2024 | 39512345 | PubTator, text mining | PubMed |
| Genome-wide studies define new genetic mechanisms of IgA vasculitis. | medRxiv | 2024 | 39417133 | PubTator, text mining | PubMed |
| The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy. | Cancer Immunol Immunother | 2024 | 39358557 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization identified potential drug targets for migraine. | J Headache Pain | 2024 | 39261750 | PubTator, text mining | PubMed |
| Blood soluble CD89-IgA complex may be a potential biomarker for predicting multi-organ involvement, especially renal involvement in children with immunoglobulin A vasculitis. | Int Immunopharmacol | 2024 | 39241523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2204/papers?page=3